This weekend ACSH trustee Dr. Henry Miller had a letter to the editor appear in the New York Times. Dr. Miller's letter called for more FDA reforms, he wrote that the agency's most significant problems are "mismanagement and a culture that is excessively risk-averse." Dr. Miller calls for "competent management, discipline in the ranks, more effective risk-benefit balancing, a commitment to permitting patients to assume more responsibility for the risk of medicines and the banishment of politics from regulatory decisions and policy." Dr. Miller's letter is not a surprise to ACSH staffers -- at a time when most scientists and doctors are afraid to speak up Dr. Miller is a welcome anomaly, always writing op-eds and letters to the editor.
